Skip to main content

13 August 2026

Last updated: Thursday 13 August 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Novartis invests in genetically-engineered T cells

Saturday 15 September 2012

Interviewee/Contributor

William Sellers

Organisation

Novartis

Organisations

VaxEquity Ltd
Aduro Biotech Inc
MRC Technology
National Institute for Biological Standards and Control
New Science Fund
Evonetix Ltd
Epigenomics AG
Virttu Biologics Ltd
Strategus
Micreos BV

Interviewees and Contributers

Roel Bellens
Will James
Steven Pearson
Jon Moulton
Monika Paulė
Geoffrey Guy
Akshay Vaishnaw
Wes Kim
Brian McGuinness and Peter Pack
Sarah Bramley

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

ViCentra appoints CFO and adds a board member

Wednesday 22 July 2026

New CEO at Simris Biologics

Wednesday 22 July 2026

New CEO at Genopore

Wednesday 22 July 2026

Camena Bioscience appoints CEO

Wednesday 22 July 2026

Lundbeck promotes research head to EVP R&D

Wednesday 22 July 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form